查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1459811

外用抗生素市场（药品类别：四环素、氨基糖苷类、红霉素、克林霉素等；产品类型：处方药和非处方药）- 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Topical Antibiotics Market (Drug Class: Tetracycline, Amino-glycosides, Erythromycin, Clindamycin, and Others; and Product Type: Prescription and OTC) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 232 Pages | 商品交期: 2-10个工作天内

价格

外用抗生素市场 - 报告范围

TMR 关于全球外用抗生素市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球外用抗生素市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球外用抗生素市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解局部抗生素市场。

市场概况
2022年市场价​​值 65 亿美元
2031 年市场价值 100 亿美元
CAGR 5.1%

该报告深入探讨了全球外用抗生素市场的竞争格局。全球外用抗生素市场的主要参与者已经确定，并对每位参与者的不同属性进行了分析。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球局部抗生素市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依药物类别

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依药品类别，2017-2031
    • 四环素
    • 氨基糖苷类
    • 红霉素
    • 克林霉素
    • 其他的
  • 市场吸引力：按药品类别

第 7 章：全球市场分析与预测：按剂型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按剂型，2017-2031
    • 药膏
    • 乳霜
    • 粉末
    • 凝胶
    • 其他的
    • 7.4 市场吸引力：按剂型

第 8 章：全球市场分析与预测：依指标分类

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依指标划分，2017-2031
    • 皮肤感染
    • 眼部感染
    • 狐狸臭
    • 其他的
  • 市场吸引力：依指标分类

第 9 章：全球市场分析与预测：依产品类型

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：依产品类型，2017-2031
    • 处方
    • 场外交易
  • 市场吸引力：按产品类型

第 10 章：全球市场分析与预测：按配销通路

  • 简介和定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2017-2031
    • 医院药房
    • 零售药局
    • 其他的
  • 市场吸引力：按配销通路划分

第 11 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力：按地区

第 12 章：北美市场分析与预测

第 13 章：欧洲市场分析与预测

第 14 章：亚太市场分析与预测

第 15 章：拉丁美洲市场分析与预测

第 16 章：中东和非洲市场分析与预测

第17章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Novartis AG
    • GlaxoSmithKline plc
    • Perrigo Company plc
    • Pfizer, Inc.
    • Almirall, SA
    • Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
    • Medimetriks Pharmaceuticals, Inc.
    • Taro Pharmaceutical Industries Ltd.
    • Mayne Pharma Group Ltd.
Product Code: TMRGL44919

Topical Antibiotics Market - Scope of Report

TMR's report on the global topical antibiotics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global topical antibiotics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global topical antibiotics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the topical antibiotics market.

Market Snapshot
Market Value in 2022US$ 6.5 Bn
Market Value in 2031US$ 10 Bn
CAGR5.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global topical antibiotics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global topical antibiotics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global topical antibiotics market.

The report delves into the competitive landscape of the global topical antibiotics market. Key players operating in the global topical antibiotics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global topical antibiotics market profiled in this report.

Key Questions Answered in Global topical antibiotics Market Report:

  • What is the sales/revenue generated by topical antibiotics across all regions during the forecast period?
  • What are the opportunities in the global topical antibiotics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Topical Antibiotics Market - Research Objectives and Research Approach

The comprehensive report on the global topical antibiotics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global topical antibiotics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global topical antibiotics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Topical Antibiotics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Topical Antibiotics Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Topical Antibiotics Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Class, 2017-2031
    • 6.3.1. Tetracycline
    • 6.3.2. Amino-glycosides
    • 6.3.3. Erythromycin
    • 6.3.4. Clindamycin
    • 6.3.5. Others
  • 6.4. Market Attractiveness, by Drug Class

7. Global Topical Antibiotics Market Analysis and Forecast, by Dosage Form

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 7.3.1. Ointments
    • 7.3.2. Creams
    • 7.3.3. Powders
    • 7.3.4. Gels
    • 7.3.5. Others
    • 7.3.6. 7.4 Market Attractiveness, by Dosage Form

8. Global Topical Antibiotics Market Analysis and Forecast, By Indication

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Indication, 2017-2031
    • 8.3.1. Skin Infection
    • 8.3.2. Eye Infection
    • 8.3.3. Bromhidrosis
    • 8.3.4. Others
  • 8.4. Market Attractiveness, By Indication

9. Global Topical Antibiotics Market Analysis and Forecast, by Product Type

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Product Type, 2017-2031
    • 9.3.1. Prescription
    • 9.3.2. OTC
  • 9.4. Market Attractiveness, by Product Type

10. Global Topical Antibiotics Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Others
  • 10.4. Market Attractiveness, by Distribution Channel

11. Global Topical Antibiotics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017-2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Topical Antibiotics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Class, 2017-2031
    • 12.2.1. Tetracycline
    • 12.2.2. Amino-glycosides
    • 12.2.3. Erythromycin
    • 12.2.4. Clindamycin
    • 12.2.5. Others
  • 12.3. Market Attractiveness, by Drug Class
  • 12.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 12.4.1. Ointments
    • 12.4.2. Creams
    • 12.4.3. Powders
    • 12.4.4. Gels
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Dosage Form
  • 12.6. Market Value Forecast, By Indication, 2017-2031
    • 12.6.1. Skin Infection
    • 12.6.2. Eye Infection
    • 12.6.3. Bromhidrosis
    • 12.6.4. Others
  • 12.7. Market Attractiveness, By Indication
  • 12.8. Market Value Forecast, by Product Type, 2017-2031
    • 12.8.1. Prescription
    • 12.8.2. OTC
  • 12.9. Market Attractiveness, by Product Type
  • 12.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.10.1. Hospital Pharmacies
    • 12.10.2. Retail Pharmacies
    • 12.10.3. Others
  • 12.11. Market Attractiveness, by Distribution Channel
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Drug Class
    • 12.13.2. By Dosage Form
    • 12.13.3. By Indication
    • 12.13.4. By Product Type
    • 12.13.5. By Distribution Channel
    • 12.13.6. By Country

13. Europe Topical Antibiotics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Class, 2017-2031
    • 13.2.1. Tetracycline
    • 13.2.2. Amino-glycosides
    • 13.2.3. Erythromycin
    • 13.2.4. Clindamycin
    • 13.2.5. Others
  • 13.3. Market Attractiveness, by Drug Class
  • 13.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 13.4.1. Ointments
    • 13.4.2. Creams
    • 13.4.3. Powders
    • 13.4.4. Gels
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Dosage Form
  • 13.6. Market Value Forecast, By Indication, 2017-2031
    • 13.6.1. Skin Infection
    • 13.6.2. Eye Infection
    • 13.6.3. Bromhidrosis
    • 13.6.4. Others
  • 13.7. Market Attractiveness, By Indication
  • 13.8. Market Value Forecast, by Product Type, 2017-2031
    • 13.8.1. Prescription
    • 13.8.2. OTC
  • 13.9. Market Attractiveness, by Product Type
  • 13.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.10.1. Hospital Pharmacies
    • 13.10.2. Retail Pharmacies
    • 13.10.3. Others
  • 13.11. Market Attractiveness, by Distribution Channel
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Drug Class
    • 13.13.2. By Dosage Form
    • 13.13.3. By Indication
    • 13.13.4. By Product Type
    • 13.13.5. By Distribution Channel
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Topical Antibiotics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Class, 2017-2031
    • 14.2.1. Tetracycline
    • 14.2.2. Amino-glycosides
    • 14.2.3. Erythromycin
    • 14.2.4. Clindamycin
    • 14.2.5. Others
  • 14.3. Market Attractiveness, by Drug Class
  • 14.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 14.4.1. Ointments
    • 14.4.2. Creams
    • 14.4.3. Powders
    • 14.4.4. Gels
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Dosage Form
  • 14.6. Market Value Forecast, By Indication, 2017-2031
    • 14.6.1. Skin Infection
    • 14.6.2. Eye Infection
    • 14.6.3. Bromhidrosis
    • 14.6.4. Others
  • 14.7. Market Attractiveness, By Indication
  • 14.8. Market Value Forecast, by Product Type, 2017-2031
    • 14.8.1. Prescription
    • 14.8.2. OTC
  • 14.9. Market Attractiveness, by Product Type
  • 14.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.10.1. Hospital Pharmacies
    • 14.10.2. Retail Pharmacies
    • 14.10.3. Others
  • 14.11. Market Attractiveness, by Distribution Channel
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Drug Class
    • 14.13.2. By Dosage Form
    • 14.13.3. By Indication
    • 14.13.4. By Product Type
    • 14.13.5. By Distribution Channel
    • 14.13.6. By Country/Sub-region

15. Latin America Topical Antibiotics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Drug Class, 2017-2031
    • 15.2.1. Tetracycline
    • 15.2.2. Amino-glycosides
    • 15.2.3. Erythromycin
    • 15.2.4. Clindamycin
    • 15.2.5. Others
  • 15.3. Market Attractiveness, by Drug Class
  • 15.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 15.4.1. Ointments
    • 15.4.2. Creams
    • 15.4.3. Powders
    • 15.4.4. Gels
    • 15.4.5. Others
  • 15.5. Market Attractiveness, by Dosage Form
  • 15.6. Market Value Forecast, By Indication, 2017-2031
    • 15.6.1. Skin Infection
    • 15.6.2. Eye Infection
    • 15.6.3. Bromhidrosis
    • 15.6.4. Others
  • 15.7. Market Attractiveness, By Indication
  • 15.8. Market Value Forecast, by Product Type, 2017-2031
    • 15.8.1. Prescription
    • 15.8.2. OTC
  • 15.9. Market Attractiveness, by Product Type
  • 15.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.10.1. Hospital Pharmacies
    • 15.10.2. Retail Pharmacies
    • 15.10.3. Others
  • 15.11. Market Attractiveness, by Distribution Channel
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Drug Class
    • 15.13.2. By Dosage Form
    • 15.13.3. By Indication
    • 15.13.4. By Product Type
    • 15.13.5. By Distribution Channel
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Topical Antibiotics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Drug Class, 2017-2031
    • 16.2.1. Tetracycline
    • 16.2.2. Amino-glycosides
    • 16.2.3. Erythromycin
    • 16.2.4. Clindamycin
    • 16.2.5. Others
  • 16.3. Market Attractiveness, by Drug Class
  • 16.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 16.4.1. Ointments
    • 16.4.2. Creams
    • 16.4.3. Powders
    • 16.4.4. Gels
    • 16.4.5. Others
  • 16.5. Market Attractiveness, by Dosage Form
  • 16.6. Market Value Forecast, By Indication, 2017-2031
    • 16.6.1. Skin Infection
    • 16.6.2. Eye Infection
    • 16.6.3. Bromhidrosis
    • 16.6.4. Others
  • 16.7. Market Attractiveness, By Indication
  • 16.8. Market Value Forecast, by Product Type, 2017-2031
    • 16.8.1. Prescription
    • 16.8.2. OTC
  • 16.9. Market Attractiveness, by Product Type
  • 16.10. Market Value Forecast, by Distribution Channel, 2017-2031
    • 16.10.1. Hospital Pharmacies
    • 16.10.2. Retail Pharmacies
    • 16.10.3. Others
  • 16.11. Market Attractiveness, by Distribution Channel
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Drug Class
    • 16.13.2. By Dosage Form
    • 16.13.3. By Indication
    • 16.13.4. By Product Type
    • 16.13.5. By Distribution Channel
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Novartis AG
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. GlaxoSmithKline plc
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. Perrigo Company plc
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Pfizer, Inc.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Almirall, SA
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Bausch Health Companies, Inc. (Valeant Pharmaceuticals International, Inc.)
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Medimetriks Pharmaceuticals, Inc.
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Taro Pharmaceutical Industries Ltd.
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Mayne Pharma Group Ltd.
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 02: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 03: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 04: Global Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 05: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 06: Global Topical Antibiotics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 09: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 10: North America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 11: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 12: North America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 15: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 16: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 17: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Europe Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 19: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 21: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 22: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 23: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 24: Asia Pacific Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 25: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 27: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 28: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 29: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 30: Latin America Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 31: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
  • Table 33: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 34: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, By Indication, 2017-2031
  • Table 35: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 36: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Topical Antibiotics Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Topical Antibiotics Market Revenue (US$ Mn), by Drug Class, 2022
  • Figure 03: Global Topical Antibiotics Market Value Share, by Drug Class, 2022
  • Figure 04: Global Topical Antibiotics Market Revenue (US$ Mn), by Dosage Form, 2022
  • Figure 05: Global Topical Antibiotics Market Value Share, by Dosage Form, 2022
  • Figure 06: Global Topical Antibiotics Market Revenue (US$ Mn), By Indication, 2022
  • Figure 07: Global Topical Antibiotics Market Value Share, By Indication, 2022
  • Figure 08: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 09: Global Topical Antibiotics Market Value Share, by Product Type, 2022
  • Figure 10: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 11: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022
  • Figure 12: Global Topical Antibiotics Market Value Share, by Region, 2022
  • Figure 13: Global Topical Antibiotics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: Global Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 15: Global Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 16: Global Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 17: Global Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 18: Global Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 19: Global Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 20: Global Topical Antibiotics Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 21: Global Topical Antibiotics Market Value Share, by Product Type, 2022
  • Figure 22: Global Topical Antibiotics Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 23: Global Topical Antibiotics Market Value Share, by Distribution Channel, 2022
  • Figure 24: Global Topical Antibiotics Market Value Share Analysis, by Region, 2022-2031
  • Figure 25: Global Topical Antibiotics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 27: North America Topical Antibiotics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Topical Antibiotics Market Value Share Analysis, by Country, 2022-2031
  • Figure 29: North America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 30: North America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 31: North America Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 32: North America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 33: North America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 34: North America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 35: North America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 36: North America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 37: North America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 38: North America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 39: Europe Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 40: Europe Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Europe Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Europe Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 43: Europe Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 44: Europe Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 45: Europe Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 46: Europe Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 47: Europe Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 48: Europe Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 49: Europe Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 50: Europe Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 51: Europe Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 52: Asia Pacific Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 53: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 54: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 55: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 56: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 57: Asia Pacific Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 58: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 59: Asia Pacific Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 60: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 61: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 62: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 63: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 64: Asia Pacific Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 65: Latin America Topical Antibiotics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Latin America Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 68: Latin America Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 69: Latin America Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 70: Latin America Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 71: Latin America Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 72: Latin America Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 73: Latin America Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 74: Latin America Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 75: Latin America Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 76: Latin America Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 77: Latin America Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 78: Middle East & Africa Topical Antibiotics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 79: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 81: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Drug Class, 2022-2031
  • Figure 82: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Dosage Form, 2022-2031
  • Figure 83: Middle East & Africa Topical Antibiotics Market Value Share Analysis, By Indication, 2022-2031
  • Figure 84: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 85: Middle East & Africa Topical Antibiotics Market Value Share Analysis, by Distribution Channel, 2022-2031
  • Figure 86: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Drug Class, 2023-2031
  • Figure 87: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 88: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, By Indication, 2023-2031
  • Figure 89: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 90: Middle East & Africa Topical Antibiotics Market Attractiveness Analysis, by Distribution Channel, 2023-2031